IXHL
Incannex Healthcare, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$2.76
−2.13%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.66
- Revenue estimate
- $10.0M
Latest reported
- Last report date
- Sep 25, 2026
- EPS actual
- -$0.14
- EPS estimate
- $0.13
- Revenue actual
- —
- Revenue estimate
- $200.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -38.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 25, 2026 | $0.13 | -$0.14 | Miss -207.69% | — |
| May 15, 2026 | -$0.60 | -$0.35 | Beat 41.67% | — |
| Sep 29, 2025 | -$0.29 | -$0.39 | Miss -34.48% | $66.6K |
| May 15, 2025 | — | -$0.34 | — | — |
| Nov 14, 2024 | — | -$0.45 | — | $109.0K |
| Sep 30, 2024 | -$0.76 | -$0.39 | Beat 48.68% | $18.0K |
| May 15, 2024 | — | -$0.59 | — | — |
| Mar 1, 2024 | — | -$0.48 | — | — |
| Dec 1, 2023 | — | $3.03 | — | — |
| Dec 31, 2022 | — | -$0.28 | — | — |
| Sep 30, 2022 | — | -$1.38 | — | — |
| Mar 31, 2022 | — | -$0.01 | — | $292.7K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026